Application no. and date | 16812334.7 (espacenet) (Federated) (European Patent Register), 20160615 | Patent/reg. no. and date | DK/EP 3307326, 20200812 | Publication date | 20180418 | Priority no. and date | US 201562175948 P, 20150615, US 201562257562 P, 20151119 | EP pub. no. and date |
EP 3307326 20180418 | Effective date | | Applicant/owner | Angiochem Inc., 201 President Kennedy Avenue Suite PK-2880
Montréal, QC H2X 3Y7, CA | Applicant ref. no. | V2009-094-DK | Inventor | CASTAIGNE, Jean-Paul, 455 Avenue Lockhart
Mont-Royal, QC H3P 1Y6, CA, LAWRENCE, Betty, 83 Waterbury Street
Bolton, ON L7E 2G1, CA, KUMTHEKAR, Priya, 1019 West Monroe Unit 1W
Chicago, IL 60607, US | Representative | | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61K 45/06 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 47/34 (2017.01) , A61K 47/64 (2017.01) , A61K 9/00 (2006.01) , A61K 9/48 (2006.01) , A61N 5/10 (2006.01) , A61P 35/00 (2006.01) | Title | FREMGANGSMÅDER TIL BEHANDLING AF LEPTOMENINGEAL KARCINOMATOSE | Int. application no. | US2016037626 | Int. publication no. | WO2016205367 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|